![These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI® FEMARA® CO-PACK (ribociclib tablets; letrozole tablets), These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI® FEMARA® CO-PACK (ribociclib tablets; letrozole tablets),](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=kisqali-copack-06.jpg&id=727703)
These highlights do not include all the information needed to use KISQALI FEMARA CO-PACK safely and effectively. See full prescribing information for KISQALI FEMARA CO-PACK. KISQALI® FEMARA® CO-PACK (ribociclib tablets; letrozole tablets),
![Novartis' Kisqali extends PFS by 1 year for advanced breast cancer patients < Pharma < Article - KBR Novartis' Kisqali extends PFS by 1 year for advanced breast cancer patients < Pharma < Article - KBR](https://cdn.koreabiomed.com/news/photo/202212/20092_20081_2238.jpg)
Novartis' Kisqali extends PFS by 1 year for advanced breast cancer patients < Pharma < Article - KBR
![Kisqali® (ribociclib) for the Treatment of HR+/HER2- Metastatic Breast Cancer - Clinical Trials Arena Kisqali® (ribociclib) for the Treatment of HR+/HER2- Metastatic Breast Cancer - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/3l-image-140.jpg)